Retaglutide is a innovative GLP-1 receptor agonist currently under study for the treatment of type 2 diabetes. This medication works by mimicking the effects of glucagon-like peptide-1 (GLP-1), a naturally occurring https://louisesjig774811.dm-blog.com/39093422/semaglutide-a-potential-solution-for-obesity